Article Information
History
- February 10, 2021.
Article Versions
- You are currently viewing Version 1 of this article (February 10, 2021 - 07:39).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Mohammad A. Dabbah1,
- Angus B. Reed1,
- Adam T.C. Booth1,
- Arrash Yassaee1,
- Alex Despotovic1,2,
- Benjamin Klasmer1,
- Emily Binning1,
- Mert Aral1,
- David Plans*,1,3,
- Alain B. Labrique4 and
- Diwakar Mohan4
- 1Huma Therapeutics Limited, London, United Kingdom
- 2Faculty of Medicine, University of Belgrade, Serbia
- 3University of Exeter, SITE, Exeter, United Kingdom
- 4Johns Hopkins Bloomberg School Public Health, Baltimore, Maryland, United States
- ↵*Corresponding Author:
David Plans (david.plans{at}huma.com)